Clinical Considerations in Renal Cell Carcinoma: Current Evidence, Guideline Recommendations, and a View to the Future

Experts discuss the recommended guidelines for managing operable, advanced, or metastatic renal cell carcinoma, including the latest data on emerging therapies and adverse event management. Download the slidsesets from a live CME/CE/CPE-certified satellite symposium presented in Chicago at ASCO 2023 and read an expert commentary.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

Supporters

Supported by educational grants from AVEO Pharmaceuticals, Inc. (“AVEO Oncology”) and Eisai. Supported by a medical education grant from Exelixis, Inc.

AVEO Pharmaceuticals, Inc.

Eisai

Exelixis, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner

In partnership with Clinical Care Options, LLC.